APA-viite

Sehgal, K., Peters, M. L. B., VanderLaan, P. A., Rangachari, D., Kobayashi, S. S., & Costa, D. B. (2018). Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer. J Thorac Oncol.

Chicago-tyylinen lähdeviittaus

Sehgal, Kartik, Mary Linton B. Peters, Paul A. VanderLaan, Deepa Rangachari, Susumu S. Kobayashi, ja Daniel B. Costa. "Activity of Brigatinib in the Setting of Alectinib Resistance Mediated By ALK I1171S in ALK-Rearranged Lung Cancer." J Thorac Oncol 2018.

MLA-viite

Sehgal, Kartik, et al. "Activity of Brigatinib in the Setting of Alectinib Resistance Mediated By ALK I1171S in ALK-Rearranged Lung Cancer." J Thorac Oncol 2018.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.